Cost‐Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis
Autor: | Stephen P. Messier, Karen C. Smith, Elena Losina, David J. Hunter, Jamie E. Collins, Jeffrey N. Katz, A. David Paltiel, Lisa G. Suter |
---|---|
Rok vydání: | 2019 |
Předmět: |
030203 arthritis & rheumatology
medicine.medical_specialty Cost effectiveness business.industry Comparative effectiveness research Overweight Quality-adjusted life year 03 medical and health sciences 0302 clinical medicine Rheumatology Quality of life Weight loss Health care medicine Physical therapy medicine.symptom business Body mass index health care economics and organizations |
Zdroj: | Arthritis Care & Research. 71:855-864 |
ISSN: | 2151-4658 2151-464X |
Popis: | Objective The Intensive Diet and Exercise for Arthritis (IDEA) trial showed that an intensive diet and exercise (D+E) program led to a mean 10.6-kg weight reduction and 51% pain reduction in patients with knee osteoarthritis (OA). The aim of the current study was to investigate the cost-effectiveness of adding this D+E program to treatment in overweight and obese (body mass index >27 kg/m2 ) patients with knee OA. Methods We used the Osteoarthritis Policy Model to estimate quality-adjusted life-years (QALYs) and lifetime costs for overweight and obese patients with knee OA, with and without the D+E program. We evaluated cost-effectiveness with the incremental cost-effectiveness ratio (ICER), a ratio of the differences in lifetime cost and QALYs between treatment strategies. We considered 3 cost-effectiveness thresholds: $50,000/QALY, $100,000/QALY, and $200,000/QALY. Analyses were conducted from health care sector and societal perspectives and used a lifetime horizon. Costs and QALYs were discounted at 3% per year. D+E characteristics were derived from the IDEA trial. Deterministic and probabilistic sensitivity analyses (PSAs) were used to evaluate parameter uncertainty and the effect of extending the duration of the D+E program. Results In the base case, D+E led to 0.054 QALYs gained per person and cost $1,845 from the health care sector perspective and $1,624 from the societal perspective. This resulted in ICERs of $34,100/QALY and $30,000/QALY. In the health care sector perspective PSA, D+E had 58% and 100% likelihoods of being cost-effective with thresholds of $50,000/QALY and $100,000/QALY, respectively. Conclusion Adding D+E to usual care for overweight and obese patients with knee OA is cost-effective and should be implemented in clinical practice. |
Databáze: | OpenAIRE |
Externí odkaz: |